AMER ASSOC CANCER RESEARCH

• 

  Publisher Of

  • A Randomized Phase II Trial of Vitamin D vs Placebo in Premenopausal Women: CALGB 70806..  Cancer Research.  71. 2011
  • Dosimetric Comparison of Radiotherapy for Left Sided Breast Cancer: Breath-Hold Versus Free-Breathing.  Cancer Research.  70. 2010
  • Association between serous invasive ovarian cancer and variants in candidate DNA damage response genes.  Cancer Research.  69. 2009
  • CTCF binding at a novel intragenic binding site is associated with elevated IGF2 expression in serous epithelial ovarian cancer.  Cancer Research.  69. 2009
  • Differential roles of DR4, DR5 and c-FLIP in regulation of geranylgeranyltransferase I inhibitor-induced augmentation of tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis.  Cancer Research.  69. 2009
  • EGFR and EGFRvIII attenuate drug-induced apoptosis in glioblastomas via mitochondrial transport and interaction with pro-apoptotic proteins:A novel EGFR/EGFRvIII-mediated mechanism in drug resistance.  Cancer Research.  69. 2009
  • Hyperthermia-induced HIF-1 activation and tumor reoxygenation.  Cancer Research.  69. 2009
  • In vitro characterization of the antitumor effects of dasatinib (BMS-354825) in combination with paclitaxel and carboplatin in human ovarian cancer cell lines.  Cancer Research.  69. 2009
  • Phosphorylation of a C-terminal tyrosine of GSTP1 by EGFR dissociates GSTP1 from the GSTP1-JNK complex leading to JNK activation in glioblastoma cells.  Cancer Research.  69. 2009
  • Prostate derived Ets factor (PDEF), an emerging biomarker in cancer.  Cancer Research.  69. 2009
  • Serine-phosphorylation of the GSTP1 protein by PKC\#945; increase GSTP1-mediated cisplatin metabolism and descrease cisplatin-induced DNA interstrand cross link formation and cisplatin sensitivity in human glioma cells.  Cancer Research.  69. 2009
  • Structural and functional analysis of Nucleophosmin I (NPM1) in human malignant gliomas.  Cancer Research.  69. 2009
  • UCN-01 is effective in targeting ovarian cancer spheroids.  Cancer Research.  69. 2009
  • Intraoperative optical breast tissue characterization device for tumor margin assessment.  Cancer Research.  69:101S-101S. 2009
  • Pediatric preclinical testing program (PPTP) evaluation of the EGFR and ErbB2 inhibitor lapatinib.  Molecular Cancer Therapeutics.  6:3471S-3471S. 2007
  • Pediatric preclinical testing program (PPTP) evaluation of the fully human anti-IGF-1R antibody SCH 717454.  Molecular Cancer Therapeutics.  6:3405S-3405S. 2007
  • Role of decreased levels of lipid phosphate phosphatase-1 in accumulation of lysophosphatidic acid in ovarian cancer.  Clinical Cancer Research : an Official Journal of the American Association for Cancer Research.  9:3534-3545. 2003
  • A phase I trial of PTK787/ZK 222584 (PTK/ZK), a novel oral VEGF-R TK inhibitor in patients with recurrent GBM..  Clinical Cancer Research : an Official Journal of the American Association for Cancer Research.  7:3665S-3665S. 2001
  • Characterization of molecular mechanisms of resistance to 1,3-bis(2-chloroethyl)-1-nitrosourea alone or in combination with O-6-benzylguanine in human medulloblastoma and rhabdomyosarcoma cell lines..  Clinical Cancer Research : an Official Journal of the American Association for Cancer Research.  7:3739S-3739S. 2001
  • Dietary glycine reduces wound healing response and tumor growth by inhibition of angiogenesis: Introduction of a new method to screen anti- and pro-angiogenic compounds..  Clinical Cancer Research : an Official Journal of the American Association for Cancer Research.  7:3704S-3704S. 2001
  • Effects of soluble Tie-2 receptor and bFGF on GFP-4T1 tumor growth and initiation of angiogenesis in BALB/C mouse dorsal skinfold window chamber..  Clinical Cancer Research : an Official Journal of the American Association for Cancer Research.  7:3658S-3658S. 2001
  • Peptidyl-camptothecins are effective topoisomerase I inhibitors and potent antitumor agents..  Clinical Cancer Research : an Official Journal of the American Association for Cancer Research.  7:3795S-3795S. 2001
  • Pharmacokinetics of CPT-11 in glioma patients: Pooled analysis of data from 4 NCI-sponsored trials (Duke university, NABTC, NABTT, NCCTG)..  Clinical Cancer Research : an Official Journal of the American Association for Cancer Research.  7:3737S-3737S. 2001
  • Ritterazine B, a new cytotoxic marine product, induces apoptosis and G2/M arrest..  Clinical Cancer Research : an Official Journal of the American Association for Cancer Research.  7:3716S-3716S. 2001
  • The FLT3 internal tandem duplication in normal karyotype adult de novo AML lacking the wildtype FLT3 gene predicts poor prognosis: A Cancer and Leukemia Group B study..  Clinical Cancer Research : an Official Journal of the American Association for Cancer Research.  7:3767S-3767S. 2001
  • Glutathione conjugate of camptothecin is cytotoxic and enhances the stability of the topoisomerase I-DNA cleavage complex..  Clinical Cancer Research : an Official Journal of the American Association for Cancer Research.  6:4511S-4511S. 2000
  • Oral administration of the specific EGFR tyrosine kinase inhibitor, ZD1839 (Iressa (TM)), is active against EGFR-overexpressing intracranial tumors..  Clinical Cancer Research : an Official Journal of the American Association for Cancer Research.  6:4542S-4543S. 2000
  • Patients' perceptions of a high-profile phase 1 trial..  Clinical Cancer Research : an Official Journal of the American Association for Cancer Research.  6:4575S-4575S. 2000
  • Increased weight & body fatness associated with chemotherapy for breast cancer ... & what can be done?.  Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology.  9:236-236. 2000
  • The p16 status of tumor cell lines identifies small molecule inhibitors specific for cyclin dependent kinase (CDK) 4..  Clinical Cancer Research : an Official Journal of the American Association for Cancer Research.  5:3755S-3756S. 1999
  • I-125-labeled anti-epidermal growth factor receptor-vIII single-chain Fv exhibits specific and high-level targeting of glioma xenografts.  Clinical Cancer Research : an Official Journal of the American Association for Cancer Research.  5:1539-1549. 1999
  • Methylator resistance mediated by mismatch repair deficiency in a glioblastoma multi forme xenograft (vol 57, pg 2933, 1997).  Cancer Research.  57:4973-4973. 1997
  • Untitled.  Clinical Cancer Research : an Official Journal of the American Association for Cancer Research.  3:1455-1455. 1997
  • ESTABLISHMENT OF A MELPHALAN-RESISTANT RHABDOMYOSARCOMA XENOGRAFT WITH CROSS-RESISTANCE TO VINCRISTINE AND ENHANCED SENSITIVITY FOLLOWING BUTHIONINE SULFOXIMINE-MEDIATED GLUTATHIONE DEPLETION.  Cancer Research.  49:6917-6922. 1989
  • 5 NEW EPITOPE-DEFINED MONOCLONAL-ANTIBODIES REACTIVE WITH GM2 AND HUMAN GLIOMA AND MEDULLOBLASTOMA CELL-LINES.  Cancer Research.  49:6645-6651. 1989
  • A PHASE-II STUDY OF POLYETHYLENE-GLYCOL (PEG) CONJUGATED L-ASPARAGINASE IN PATIENTS WITH REFRACTORY ACUTE LEUKEMIAS.  Proceedings of the American Association for Cancer Research.  29:213-213. 1988
  • LOSS OF EPIDERMAL GROWTH-FACTOR RECEPTOR GENE AMPLIFICATION AS MALIGNANT HUMAN GLIOMAS ESTABLISH IN CULTURE.  Proceedings of the American Association for Cancer Research.  29:78-78. 1988
  • METHOTREXATE (MTX), SCHEDULE DEPENDENT DRUG ACCUMULATION.  Proceedings of the American Association for Cancer Research.  29:288-288. 1988
  • SCHEDULE-DEPENDENT ENHANCED LETHAL TOXICITY IN MICE WITH COMBINED ADMINISTRATION OF ACTINOMYCIN-D AND TUMOR NECROSIS FACTOR.  Proceedings of the American Association for Cancer Research.  29:512-512. 1988
  • SELECTIVE BUTHIONINE SULFOXIMINE (BSO)-MEDIATED DEPLETION OF GLUTATHIONE (GSH) IN AN INTRACRANIAL HUMAN GLIOMA-DERIVED XENOGRAFT.  Proceedings of the American Association for Cancer Research.  29:357-357. 1988
  • TOXICITY FROM RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY STIMULATING FACTOR (RHUGM-CSF) AFTER HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS BONE-MARROW TRANSPLANT (ABMT).  Proceedings of the American Association for Cancer Research.  29:53-53. 1988
  • A SYNTHETIC PEPTIDE HOMOLOGOUS TO RETROVIRAL ENVELOPE PROTEINS INHIBITS MONOCYTE-MEDIATED KILLING BY INACTIVATING INTERLEUKIN-1 (IL-1).  Proceedings of the American Association for Cancer Research.  28:340-340. 1987
  • AMPLIFICATION AND EXPRESSION OF THE EPIDERMAL GROWTH-FACTOR RECEPTOR (EGFR) GENE IN HUMAN GLIOMA (HGL) XENOGRAFTS.  Proceedings of the American Association for Cancer Research.  28:23-23. 1987
  • EXPERIMENTAL RADIOTHERAPY OF SUBCUTANEOUS (SC) AND INTRACRANIAL (IC) HUMAN GLIOMA (HGL) XENOGRAFTS IN RODENTS WITH I-131 MONOCLONAL-ANTIBODY (MAB) 81C6.  Proceedings of the American Association for Cancer Research.  28:392-392. 1987
  • MELPHALAN CYTOTOXICITY AND RESISTANCE IN MEDULLOBLASTOMA (MBT).  Proceedings of the American Association for Cancer Research.  28:447-447. 1987
  • MODULATION OF PERITONEAL MACROPHAGE (MP) MEMBRANE-ANTIGENS BY ALPHA2-MACROGLOBULIN TRYPSIN (A2M-T) COMPLEXES.  Proceedings of the American Association for Cancer Research.  28:343-343. 1987
  • PRODUCTION AND PARTIAL CHARACTERIZATION OF A PROSTATE CARCINOMA-DIRECTED MAB.  Proceedings of the American Association for Cancer Research.  28:390-390. 1987
  • THERAPEUTIC SYNERGY OF THIOPURINES AND ALKYLATING DRUGS IN A HUMAN GLIOMA XENOGRAFT.  Proceedings of the American Association for Cancer Research.  28:416-416. 1987
  • TUMOR-NECROSIS-FACTOR INDUCES TISSUE FACTOR ACTIVITY IN HUMAN-LEUKEMIA CELL-LINE U937.  Proceedings of the American Association for Cancer Research.  28:400-400. 1987
  • TEMPERATURE-MEASUREMENTS IN NORMAL AND TUMOR-TISSUE OF DOGS UNDERGOING WHOLE-BODY HYPERTHERMIA.  Cancer Research.  46:6229-6235. 1986
  • USE OF A MONOCLONAL ANTIESTROGEN RECEPTOR ANTIBODY IN THE IMMUNOHISTOCHEMICAL EVALUATION OF HUMAN-TUMORS.  Cancer Research.  46:4244-4248. 1986
  • CHEMOTHERAPY OF HUMAN MEDULLOBLASTOMA WITH CLASSICAL ALKYLATORS.  Proceedings of the American Association for Cancer Research.  27:381-381. 1986
  • ELIMINATION OF MALIGNANT CLONOGENIC T-CELLS FROM BONE-MARROW USING CHEMOIMMUNOSEPARATION WITH AN IMMUNOTOXIN AND 2'-DEOXYCOFORMYCIN-DEOXYADENOSINE (DCF/DADO).  Proceedings of the American Association for Cancer Research.  27:380-380. 1986
  • HIGH-DOSE BUSULFAN (BU) WITH AUTOLOGOUS BONE-MARROW SUPPORT (ABMS) - A PHASE-I TRIAL.  Proceedings of the American Association for Cancer Research.  27:236-236. 1986
  • KARYOTYPIC FINDINGS IN 6 CASES OF HUMAN MEDULLOBLASTOMA.  Proceedings of the American Association for Cancer Research.  27:36-36. 1986
  • LOCALIZATION OF ANTI-HUMAN GLIOMA MONOCLONAL-ANTIBODIES (MABS) IN SUBCUTANEOUS (SC) AND INTRACEREBRAL (IC) GLIOMA XENOGRAFTS.  Proceedings of the American Association for Cancer Research.  27:330-330. 1986
  • CHROMOSOMAL ANALYSIS OF HUMAN GLIOMAS THROUGH SERIAL TRANSPLANTATION IN ATHYMIC NUDE-MICE.  Proceedings of the American Association for Cancer Research.  26:32-32. 1985
  • COMPARISON OF INTRAVENOUS VERSUS INTRACAROTID THERAPY WITH 1,3-BIS(2-CHLOROETHYL)-1-NITROSOUREA IN A RAT-BRAIN TUMOR-MODEL.  Cancer Research.  45:5240-5245. 1985
  • GLUTAMINE BASED COMBINATION CHEMOTHERAPY IN CULTURE FOR HUMAN GLIOMA AND MEDULLOBLASTOMA.  Proceedings of the American Association for Cancer Research.  26:323-323. 1985
  • INVITRO VERSUS INVIVO CORRELATIONS OF CHEMOSENSITIVITY OF HUMAN MEDULLOBLASTOMA - REPLY.  Cancer Research.  45:6538-6538. 1985
  • SENSITIVITY OF HUMAN MEDULLOBLASTOMA (MED) TO CLASSICAL ALKYLATORS.  Proceedings of the American Association for Cancer Research.  26:330-330. 1985
  • EFFECTS OF DIETHYLDITHIOCARBAMATE AND 9 OTHER NUCLEOPHILES ON THE INTERSUBUNIT PROTEIN CROSS-LINKING AND INACTIVATION OF PURIFIED HUMAN ALPHA-2-MACROGLOBULIN BY CIS-DIAMMINEDICHLOROPLATINUM(II).  Cancer Research.  44:5764-5770. 1984
  • INVITRO AND INVIVO CHEMOSENSITIVITY OF HUMAN MEDULLOBLASTOMA.  Proceedings of the American Association for Cancer Research.  25:376-376. 1984
  • IONIZED BASE-PAIRS - A PROBABLE CONSEQUENCE OF MUTAGENIC ALKYLATION OF DNA.  Proceedings of the American Association for Cancer Research.  25:20-20. 1984
  • KARYOTYPIC EVOLUTION OF HUMAN GLIOBLASTOMA-MULTIFORME (HGM) DURING ESTABLISHMENT IN CULTURE.  Proceedings of the American Association for Cancer Research.  25:36-36. 1984
  • RECOMBINANT GAMMA INTERFERON (IFN-GAMMA) AND 1,25 DIHYDROXY VITAMIN-D3 (D3) INDUCE MONOCYTOID DIFFERENTIATION AND POLYKARYON FORMATION OF HUMAN-LEUKEMIA (HL-60) CELLS-INVITRO.  Proceedings of the American Association for Cancer Research.  25:44-44. 1984
  • RECOMBINANT GAMMA INTERFERON (IFN-GAMMA) INDUCES HUMAN MONOCYTE ACTIVATION AND POLYKARYON FORMATION.  Proceedings of the American Association for Cancer Research.  25:267-267. 1984
  • SPONTANEOUS LYMPHATIC METASTASIS BY HUMAN-PROSTATE CARCINOMA-CELLS IN TUMOR-BEARING ATHYMIC NUDE-MICE.  Proceedings of the American Association for Cancer Research.  25:56-56. 1984
  • THE UTILITY OF THERMAL DOSE AS A PREDICTOR OF TUMOR AND NORMAL TISSUE RESPONSES TO COMBINED RADIATION AND HYPERTHERMIA.  Cancer Research.  44:4772-4780. 1984
  • AN APPROACH TO CONDUCTING EPIDEMIOLOGIC RESEARCH IN COOPERATIVE CLINICAL-TRIALS GROUPS.  Proceedings of the American Association for Cancer Research.  24:190-190. 1983
  • CLINICAL-TRIAL OF DTIC, CCNU, BLEOMYCIN, AND VINCRISTINE (BOLD) CHEMOTHERAPY FOR METASTATIC MELANOMA.  Proceedings of the American Association for Cancer Research.  24:143-143. 1983
  • CONVERSION OF T-CELL TO MYELOID-LEUKEMIA BY DEOXYCOFORMYCIN (DCF), A POTENT ADENOSINE-DEAMINASE (ADA) INHIBITOR.  Proceedings of the American Association for Cancer Research.  24:19-19. 1983
  • CORRELATION BETWEEN INITIAL AND LONG-TERM RESPONSES OF SPONTANEOUS PET ANIMAL TUMORS TO HEAT AND RADIATION OR RADIATION ALONE.  Cancer Research.  43:5735-5741. 1983
  • HUMAN-TUMOR CELLS AND MITOGEN-STIMULATED MONONUCLEAR-CELLS CONTAIN AN ANTIGEN RELATED TO RETROVIRAL P15E.  Proceedings of the American Association for Cancer Research.  24:237-237. 1983
  • METHYLATION OF DEOXYCYTIDINE INCORPORATED BY REPAIR SYNTHESIS FOLLOWING DAMAGE WITH ULTRAVIOLET-RADIATION AND CHEMICAL CARCINOGENS.  Proceedings of the American Association for Cancer Research.  24:335-335. 1983
  • ANTIGENIC HETEROGENEITY OF AN ESTABLISHED HUMAN GLIOMA CELL-LINE (HGCL) AND 8 SINGLE CELL DERIVED CLONES AS DEFINED BY SPECIFIC ANTI-GLIOMA MONOCLONALANTIBODIES (MCA).  Proceedings of the American Association for Cancer Research.  23:271-271. 1982
  • DEVELOPMENT OF A UNIFORM HEATING TECHNIQUE FOR THE ARIZONA CHAMBER WITH MEASUREMENT OF SINGLE VESSEL FLOW ALTERATIONS DURING HYPERTHERMIA.  Proceedings of the American Association for Cancer Research.  23:27-27. 1982
  • EFFECTS OF INTERFERON THERAPY ON MONOCYTE FUNCTIONS OF CANCER-PATIENTS.  Proceedings of the American Association for Cancer Research.  23:241-241. 1982
  • SPECIFIC PHORBOL DIESTER RECEPTORS ON NORMAL AND LEUKEMIC BLOOD-CELLS - RELATIONSHIPS OF BINDING TO CELLULAR-RESPONSES.  Proceedings of the American Association for Cancer Research.  23:102-102. 1982
  • TREATMENT OF HUMAN-BRAIN TUMORS IN ATHYMIC MICE WITH AZIRIDINYLBENZOQUINONE (AZQ).  Proceedings of the American Association for Cancer Research.  23:176-176. 1982
  • CHARACTERIZATION OF MONOCLONAL-ANTIBODIES TOHUMAN PANCREATIC TUMOR-CELLS.  Proceedings of the American Association for Cancer Research.  22:301-301. 1981
  • FACTORS INFLUENCING SEX-DIFFERENCES IN SURVIVAL FOR PATIENTS WITH MELANOMA.  Proceedings of the American Association for Cancer Research.  22:163-163. 1981
  • HUMAN MONONUCLEAR PHAGOCYTES - INVIVO DIFFERENTIATION OF BLOOD MONOCYTES TO PERITONEAL-MACROPHAGES WITH ENHANCED TUMORICIDAL ACTIVITY.  Proceedings of the American Association for Cancer Research.  22:309-309. 1981
  • SERIAL TRANSPLANTATION OF ANAPLASTIC HUMAN GLIOMAS (HGL) IN ATHYMIC MICE.  Proceedings of the American Association for Cancer Research.  22:61-61. 1981
  • COMPARATIVE-ANALYSIS OF SEX STEROID BINDING IN HUMAN-MELANOMA.  Proceedings of the American Association for Cancer Research.  21:476-476. 1980
  • DEPRESSION OF MURINE MACROPHAGE ACCUMULATION BY FACTORS DERIVED FROM SPONTANEOUS MAMMARY CARCINOMAS.  Proceedings of the American Association for Cancer Research.  21:217-217. 1980
  • IMMUNOTHERAPY OF MURINE LEUKEMIA .3. ABSENCE OF MACROPHAGE INVOLVEMENT IN THE PASSIVE SERUM THERAPY OF FRIEND-LEUKEMIA VIRUS-INDUCED DISEASE.  Cancer Research.  40:557-562. 1980
  • SPECIFIC ACTIVE IMMUNIZATION IN MELANOMA - PROGNOSTIC FACTORS.  Proceedings of the American Association for Cancer Research.  21:131-131. 1980
  • SPECIFIC ISOTOPIC SCAN LOCALIZATION OF HUMAN-MELANOMA USING IODINATED MONOSPECIFIC ANTIBODY.  Proceedings of the American Association for Cancer Research.  21:200-200. 1980
  • DIHYDROFOLATE-REDUCTASE IN PRIMARY BRAIN TUMORS, CELL-CULTURES OF CENTRAL NERVOUS-SYSTEM ORIGIN, AND NORMAL BRAIN DURING FETAL AND NEONATAL GROWTH.  Cancer Research.  39:487-491. 1979
  • PHASE-II STUDY OF BLEOMYCIN, ONCOVIN LOMUSTINE AND DTIC (BOLD) IN STAGE-IV METASTATIC MELANOMA.  Proceedings of the American Association for Cancer Research.  20:427-427. 1979
  • ORGAN-SPECIFIC, FETAL BRAIN, AND POSSIBLE IDIOTYPIC ANTIGENS OF HUMAN GLIAL BRAIN TUMOR (HGBT) CELLS.  Proceedings of the American Association for Cancer Research.  19:161-161. 1978
  • PARTIAL ISOLATION OF HUMAN MELANOMA TUMOR ASSOCIATED ANTIGENS.  Proceedings of the American Association for Cancer Research.  19:12-12. 1978
  • 3 ANTIGENS OF NITROSOUREA-INDUCED (NU) RAT SCHWANNOMAS.  Proceedings of the American Association for Cancer Research.  18:90-90. 1977
  • COMMON SURFACE ANTIGEN(S) [HGL] OF HUMAN GLIAL BRAIN TUMOR [HGBT] CELLS.  Proceedings of the American Association for Cancer Research.  18:120-120. 1977
  • DIHYDROFOLATE-REDUCTASE LEVELS IN NORMAL BRAIN AND PRIMARY CNS TUMORS RELEVANT TO BRAIN TUMOR CHEMOTHERAPY.  Proceedings of the American Association for Cancer Research.  18:177-177. 1977
  • ANALYSIS OF ANTIBODIES TO SURFACE ANTIGENS ON NEUROECTODERMAL TUMOR-CELLS USING AN INDIRECT SEQUENTIAL ADSORPTION RADIOIMMUNOASSAY.  Proceedings of the American Association for Cancer Research.  17:66-66. 1976
  • ENZYMATIC SUSCEPTIBILITY AND PARTIAL ISOLATION OF A MELANOMA ASSOCIATED ANTIGEN.  Proceedings of the American Association for Cancer Research.  17:213-213. 1976
  • INDUCTION OF LETHAL EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS (EAE) IN NON-HUMAN PRIMATES WITH HUMAN GLIOBLASTOMA MULTIFORME (GBM).  Proceedings of the American Association for Cancer Research.  17:123-123. 1976
  • Wound angiogenesis in healthy volunteers using OPSI technology: A potential surrogate marker for antiangiogenesis agents..  Clinical Cancer Research : an Official Journal of the American Association for Cancer Research.  7:3700S-3700S. 2001
  • The effects of CCL3 on dendritic cell migration and immune cell activation..  Cancer Immunology Research. 74-75. 2020
  • Trastuzumab therapy suppresses HER2+breast tumor growth through inducing ADCP by tumor-associated macrophages and synergizes with CD47 checkpoint blockade..  Cancer Immunology Research. 84-84. 2020
  • Blocking proinvasive signaling and inflammatory activation in triple-negative breast cancer with nucleic-acid scavengers (NAS)..  Cancer Immunology Research. 76-76. 2020
  • Dormant breast tumor cells avoid the adaptive immune system through regulation of the immune and tumor microenvironment..  Cancer Immunology Research. 139-140. 2020
  • Impact of CaMKK2 inhibition in tumor-associated myeloid cells on CD8+cytotoxic T-cell recruitment into mammary tumors..  Cancer Immunology Research. 56-57. 2020
  • Overexpression of MAVS stimulates antitumor immunity and significantly reduces tumor growth of immune-insensitive colorectal cancer in vivo..  Cancer Immunology Research. 24-25. 2020
  • PR2 Overexpression of MAVS stimulates antitumor immunity and significantly reduces tumor growth of immune-insensitive colorectal cancer in vivo..  Cancer Immunology Research. 53-54. 2020
  • Pharmacologic targeting of estrogen receptor in melanoma to enhance antitumor immunity..  Cancer Immunology Research. 53-53. 2020
  • Alternative RNA splicing and prostate cancer aggressiveness..  Cancer Research. 111-112. 2018
  • Defining new drivers of castration- resistant prostate cancer.  Cancer Research. 90-90. 2018
  • Oncogenic convergence of normal human prostate epithelial cells to a small cell neuroendocrine phenotype..  Cancer Research. 108-108. 2018
  • Stem cell-directed pan-cancer analysis reveals a human adult stem cell signature that defines aggressive epithelial cancer subtypes..  Cancer Research. 119-119. 2018
  • Attitudes, perceptions, and strategies toward increasing cancer screening, treatment, and participation in research among Latinos..  Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology. 115-115. 2018
  • Determinants of delays in care-seeking for ovarian cancer symptoms in African American women..  Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology. 167-168. 2018
  • Developing effective community and health system partnerships to advance health equity and health disparities research..  Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology. 34-34. 2018
  • Development of a novel therapeutic splice-switching oligonucleotide targeting race-related androgen receptor signaling and aggressive prostate cancer..  Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology. 46-46. 2018
  • Efficacy of GLI antagonists in triple-negative inflammatory breast cancer 2D and 3D models.  Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology. 131-132. 2018
  • Establishment of African American prostate cancer patient-derived primary cell lines and xenografts..  Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology. 96-96. 2018
  • Nutritional profiling reveals glutamine-utilizing transaminases as a metabolic vulnerability of TAZ/YAP-driven breast cancer cells.  Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology. 148-148. 2018
  • Race-related differential splicing of the insulin receptor: A novel target underlying prostate cancer disparities.  Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology. 138-139. 2018
  • Detection of mutations in single tumor cells collected by fine needle aspiration in a mouse xenograft breast cancer model using MALDI-TOF.  Cancer Research. 2018
  • Incidence and mortality among breast cancer patients < 40 years old: US trends from 1992-2014.  Cancer Research. 2018
  • Is it cancer or not? A qualitative exploration of patient perspectives surrounding the diagnosis and treatment of DCIS.  Cancer Research. 2018
  • Prediction of occult invasive disease in ductal carcinoma in situ using deep learning features.  Cancer Research. 2018
  • Primary endocrine therapy for ER-positive ductal carcinoma in situ (DCIS) CALGB 40903 (Alliance).  Cancer Research. 2018
  • Quantifying the natural history and overtreatment rate of ductal carcinoma in situ.  Cancer Research. 2018
  • Trajectory patterns of circulating tumor cells (CTC) in chemotherapy-treated metastatic breast cancer (MBC) patients predict poor clinical outcomes: CALGB 40502 (Alliance)/NCCTG N063H study.  Cancer Research. 2018
  • Generation and comparison of CRISPR/Cas9 and Cre-mediated genetically engineered mouse models of sarcoma.  Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. 44-45. 2018
  • Modeling the tumor microenvironment in sarcoma: The impact on MPNST biology and chemotherapeutic response..  Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. 31-31. 2018
  • Dietary patterns and cancer mortality among African Americans and Whites in the REGARDS cohort.  Cancer Research. 2016
  • Rates of adherence and persistence to adjuvant endocrine therapy among women enrolled in Medicare Part D in a four-state region of Appalachia.  Cancer Research. 2015
  • Flat epithelial atypia diagnosed on breast core biopsy: what next?.  Cancer Research. 2012
  • Patterns of definitive axillary management in the era prior to reporting ACOSOG Z0011: comparison between NCCN Centers and hospitals in Michigan.  Cancer Research. 2012
  • The predictive value of a 5-gene signature as a patient pre-selection tool in medulloblastoma for Hedgehog pathway inhibitor therapy.  Cancer Research. 2012
  • Bayesian Belief Network Mortality Analysis of a Breast Cancer Registry Data Set..  Cancer Research. 2011
  • Feasibility of Preoperative Single Fraction Partial Breast Radiotherapy for Early Stage Breast Cancer.  Cancer Research. 741S-741S. 2009
  • Practice and Attitudes towards CYP2D6 Testing for Patients on Tamoxifen among US Oncologists.  Cancer Research. 563S-563S. 2009
  • : Apolipoprotein-E mimetic peptides mediate cytotoxicity in CLL: The role of PP2a and SET.  Cancer Research. 2009
  • Apolipoprotein-E mimetic peptides mediate cytotoxicity in CLL: The role of PP2a and SET.  Cancer Research. 2009
  • Complex hyperplasia with and without atypia - clinical outcomes and implications of progestin therapy in a 20 year cohort study of 1510 women.  Cancer Research. 2009
  • Epidermal-specific expression of a CYLD mutant leads to increased sensitivity to skin carcinogenesis and metastasis.  Cancer Research. 2009
  • Nuclear expression of transcription factors Stat5a and Stat5b confers favorable prognosis in breast cancer.  Cancer Research. 2009
  • PP2A-dependent dephosphorylation of replication protein A (RPA) is required for the removal of DNA breaks induced by replication stress.  Cancer Research. 2009
  • Podoplanin is a novel antibody-based therapeutic target for glioblastoma.  Cancer Research. 2009
  • Role of lactate as a fuel in a unique microenvironmentally controlled metabolic symbiont.  Cancer Research. 2009
  • Toll-like receptor 9 (TLR9) interacts with ErbB receptors at membrane level and a TLR9 agonist synergizes with trastuzumab in trastuzumab-resistant breast cancer xenografts via modulation of ErbB signalling.  Cancer Research. 2009
  • A phase II study to optimize dasatinib dosing in metastatic breast cancer patients using real-time pharmacodynamic tissue and urinary biomarkers.  Cancer Research. 238S-239S. 2009
  • A randomized phase 2 trial of low dose (6 mg daily) versus high dose (30 mg daily) estradiol for patients with estrogen receptor positive aromatase inhibitor resistant advanced breast cancer.  Cancer Research. 67S-68S. 2009
  • Antibody-based immunotherapy: targeting CSPG4 on human basal breast cancer stem cells.  Cancer Research. 314S-315S. 2009
  • Assays of circulating tumor cells and outcome in the triple-negative breast cancer trial TBCRC001..  Cancer Research. 360S-361S. 2009
  • Survival outcome is similar for first-line chemotherapy with capecitabine or taxane for metastatic breast cancer.  Cancer Research. 374S-374S. 2009
  • Efficacy and immunologic effects of RNA-pulsed dendritic cell vaccines targeting human cytomegalovirus antigens in patients with glioblastoma.  Cancer Research. 2008
  • A novel role of DNA fragmentation factor as a tumor suppressor through maintaining genetic stability.  Cancer Research. 2006
  • Age and menopausal effects of hormonal birth control and hormone replacement therapy in relation to breast cancer risk.  Cancer Research. 2006
  • Characterization of membrane transport of the novel O-6-alkylguanine-DNA alkyltransferase inactivator, O-4-benzylfolic acid.  Cancer Research. 2006
  • Characterization of the HSP70 co-chaperone HspBP1 in brain tumors.  Cancer Research. 2006
  • Characterizing oligodendroglioma rearrangements using whole genome hrCGH arrays.  Cancer Research. 2006
  • Combination therapy of bevacizumab with rapamycin in antitumor activity..  Cancer Research. 2006
  • Constitutive phosphorylation of Chk1 at serine 317 in a medulloblastoma cell line is sensitive to the inhibition of the phosphatidyalinositol-3-kinase-related kinase (PIKK) pathway.  Cancer Research. 2006
  • Cytoplasmic tyrosine kinase c-Abl is required for bFGF but not VEGF-induced tumor angiogenesis.  Cancer Research. 2006
  • Depletion of regulatory T cells increases the in vivo CEA specific T cell response.  Cancer Research. 2006
  • Development of cellular models and small GTPases-targeted therapeutics for inflammatory breast cancer.  Cancer Research. 2006
  • EGFR phosphorylates Glutathione S-Transferase P1 (GSTP1), a novel downstream target, in human glioma cells.  Cancer Research. 2006
  • Effects of tumor tissue collagen content on the flow rate during intratumoral infusion.  Cancer Research. 2006
  • Evaluation of 17-dimethylaminoethylamino-17-demethoxygeldanamycin (17-DMAG, KOS-1022) against Childhood Cancer Models by the Pediatric Preclinical Testing Program (PPTP).  Cancer Research. 2006
  • Frequent overexpression of prostate derived ets factor (PDEF) protein in breast cancer progression.  Cancer Research. 2006
  • Genetic polymorphism of the Epidermal Growth Factor (EGF) gene in glioma patients: Distribution and correlation with Survival.  Cancer Research. 2006
  • Identification of DNA copy number abnormalities associated with the metastatic phenotype of human breast cancer using a high resolution whole genome approach.  Cancer Research. 2006
  • Identification of methylation hotspots in the GSTP1 region associated with transcriptional silencing of the GSTP1 gene in human gliomas.  Cancer Research. 2006
  • Imaging alternative splicing in prostate tumors reveals mesenchymal-epithelial transitions in vivo.  Cancer Research. 2006
  • Induction of Wilms' tumor protein (WT1)-specific immunity using a WT1-expressing adenovirus vaccine.  Cancer Research. 2006
  • Molecular characterization of the role of OTX2 in medulloblastoma pathogenesis.  Cancer Research. 2006
  • Molecular epidemiology of cyclin E overexpression in epithelial ovarian cancer.  Cancer Research. 2006
  • O-6-alkylguanine-DNA alkyltransferase (AGT) and microsatellite instability (MSI) analyses in malignant glioma.  Cancer Research. 2006
  • Overexpression of imprinted DLK1 in epithelial ovarian cancer.  Cancer Research. 2006
  • Pharmacogenetics, molecular correlates and multiparameter high throughput evaluation of the response of inflamatory breast cancer cells to anticancer agents.  Cancer Research. 2006
  • Polymorphisms of glutathione-S-transferase and N-acetyltransferase genes and response to treatment in childhood neuroblastoma.  Cancer Research. 2006
  • Profiling of DNA copy number changes in sarcomas by array comparative genomic hybridization.  Cancer Research. 2006
  • Prognostic significance of OTX2 in medulloblastoma.  Cancer Research. 2006
  • Replication-competent packaging-deficient [E1+, 100k-] adenoviral vector-transduced dendritic cells can efficiently induce antigen-specific immune responses.  Cancer Research. 2006
  • Secreted protein acidic and rich in cysteine (SPARC) activates focal adhesion kinase and integrin-linked kinase to induce AKT-dependent glioma survival and invasion.  Cancer Research. 2006
  • Targeted approaches to the treatment of ovarian cancer..  Cancer Research. 2006
  • Targeted drug delivery for neuroblastoma using MIBG..  Cancer Research. 2006
  • Targeted drug delivery to solid tumors using thermally responsive elastin-like polypeptide macromolecular drug carriers.  Cancer Research. 2006
  • Targeting of malignant gliomas with GPNMB-specific single-chain antibody fragment (scFv) and recombinant immunotoxin.  Cancer Research. 2006
  • The tetraspanin superfamily member NET-6 is a new breast cancer suppressor gene.  Cancer Research. 2006
  • Treatment with gleevec in NSCLC xenografts decreases proliferative capillary index and improves drug delivery.  Cancer Research. 2006
  • YY1 imprint status and role in ovarian carcinogenesis.  Cancer Research. 2006
  • A phase I trial of AP23573, a novel mTOR inhibitor, in patients (Pts) with recurrent malignant glioma..  Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. 9012S-9012S. 2005
  • Evaluation of bortezomib against childhood tumor models by the pediatric preclinical testing program (PPTP).  Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. 8987S-8988S. 2005
  • Expression profiling of CD4+ and CD8+ T cells in malignant glioma..  Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. 8999S-8999S. 2005
  • Gene expression models for recurrence risk prediction coupled with patterns of oncogenic pathway deregulation provide a novel therapeutic strategy for patients with non-small cell lung carcinoma..  Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. 8997S-8998S. 2005
  • PI3K and TGF beta pathways interact functionally and therapeutically to regulate cellular motility and invasion in malignant glioma..  Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. 9134S-9134S. 2005
  • Oncogenic pathway signatures in human cancers as a guide to targeted therapies..  Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology. 2743S-2743S. 2005
  • Results from project LEAD (Leading the way in Exercise And Diet): A lifestyle intervention trial aimed at older adults diagnosed with breast and prostate cancer..  Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology. 2809S-2809S. 2005
  • The molecular pharmacology of estrogen receptor modulators: Implications for the treatment of breast cancer.  Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. 871S-877S. 2005
  • Childhood cancer survivors: Health behaviors and receptivity to health promotion interventions..  Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology. 1939S-1939S. 2004
  • Screening for therapy-related second cancers..  Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology. 1954S-1954S. 2004
  • Trinucleotide repeat polymorphisms in the androgen receptor gene and risk of ovarian cancer..  Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology. 1897S-1897S. 2004
  • Androgen receptor downregulation in prostate cancer with phosphorodiamidate morpholino antisense oligomers..  Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. 6084S-6084S. 2003
  • Astatine-211 labeled Herceptin: An alpha-particle emitting radiotherapeutic..  Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. 6189S-6189S. 2003
  • Combination therapy of inhibitors of the epidermal growth factor/vascular endothelial growth factor receptor 2 (AEE788) and the mammalian target of rapamycin (RAD001) offers improved glioblastoma tumor growth inhibition..  Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. 6090S-6090S. 2003
  • SB431542, a small molecule transforming growth factor-beta-receptor antagonist, inhibits human glioma xenograft malignant phenotype..  Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. 6236S-6236S. 2003
  • ZD6474, a vascular endothelial growth factor receptor 2 (VEGFR-2) inhibitor, inhibits growth of multiple primary central nervous system tumor types..  Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. 6143S-6143S. 2003
  • Progesterone receptor promoter+331/G/A polymorphism is associated with deceased risk of epithelial ovarian cancer..  Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology. 1340S-1340S. 2003
  • Imsulin-like growth factor-1 (IGF-1): An exploration of serum levels, binding protein (IGFBP-3) and IGF-1 CA repeat genotype, and the risk of prostae cancer.  Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology. 182-182. 2003
  • A case-control study of candidate ovarian cancer susceptibility polymorphisms..  Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology. 1165S-1165S. 2002
  • Effects of a low fat, flaxseed-supplemented diet on men with prostatic intraepithelial neoplasia (PIN) or atypia..  Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology. 1171S-1171S. 2002
  • Evaluation of ovarian cancer preventive agents in the chicken..  Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology. 1193S-1193S. 2002
  • Randomized controlled clinical trial of weekly oltipraz in smokers..  Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology. 1169S-1169S. 2002
  • Evaluation of new expression-based markers for detection of breast cancer cells..  Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. 3688S-3688S. 2001
  • RADIOIMMUNOTHERAPY OF BREAST-CANCER XENOGRAFTS WITH MONOCLONAL-ANTIBODY ICR12 AGAINST C-ERBB2 P185 - COMPARISON OF IODOGEN AND N-SUCCINIMIDYL 4-METHYL-3-(TRI-N-BUTYLSTANNYL)BENZOATE RADIOIODINATION METHODS.  Cancer Research. S5842-S5846. 1995
  • DETECTION OF SULFOMUCIN EXPRESSION IN COLONIC MUCOSA, PRIMARY COLON-CARCINOMA AND METASTASES USING A SPECIFIC MONOCLONAL-ANTIBODY (91.9H).  Proceedings of the American Association for Cancer Research. 63-63. 1988
  • EFFECT OF HIGH-DOSE ALKYLATING-AGENTS ON ENDOMYOCARDIAL GLUTATHIONE LEVELS AND CARDIAC-PERFORMANCE IN MAN.  Proceedings of the American Association for Cancer Research. 268-268. 1988
  • INCREASED EXPRESSION OF COLON-CARCINOMA SIALOMUCIN INDUCED BY NORMAL TISSUE FACTORS AND ITS ASSOCIATION WITH IMMUNE EFFECTOR RESISTANCE.  Proceedings of the American Association for Cancer Research. 400-400. 1988
  • MODULATION OF DIFLUOROMETHYLORNITHINE TOXICITY BY CONCOMITANT ORNITHINE TREATMENT IN TUMOR-BEARING RATS.  Proceedings of the American Association for Cancer Research. 346-346. 1988
  • ADHESIVE PROPERTIES OF HUMAN-COLON CARCINOMA-CELLS ESTABLISHED FROM PRIMARY TUMOR AND METASTASES.  Proceedings of the American Association for Cancer Research. 73-73. 1987
  • DIFFERENTIAL EFFECT OF DIFLUOROMETHYLORNITHINE (DFMO) ON HEPATIC AND TUMOR POLYAMINE METABOLISM IN SARCOMA-BEARING RATS.  Proceedings of the American Association for Cancer Research. 319-319. 1987
  • POLYAMINE DIRECTED PREFERENTIAL NUTRITIONAL REPLETION OF NORMAL-TISSUES IN TUMOR-BEARING HOSTS.  Proceedings of the American Association for Cancer Research. 317-317. 1987
  • TUMOR-CELL VIABILITY IN SUBPOPULATIONS OF HUMAN-BREAST CANCER.  Proceedings of the American Association for Cancer Research. 34-34. 1987
  • UNSCHEDULED DNA-SYNTHESIS (UDS) IN XENOGRAFTS CONTAINING RAT OR HUMAN RESPIRATORY EPITHELIAL-CELLS.  Proceedings of the American Association for Cancer Research. 114-114. 1987
  • ANTITUMOR-ACTIVITY AND HOST TOXICITY OF CONTINUOUS INTRAVENOUS (IV) ALPHA-DIFLUOROMETHYLORNITHINE (DFMO).  Proceedings of the American Association for Cancer Research. 292-292. 1986
  • COLLAGENOLYTIC ACTIVITIES OF HUMAN COLORECTAL-CARCINOMA AT DIFFERENT STAGES.  Proceedings of the American Association for Cancer Research. 58-58. 1986
  • SULFATED GLYCOCONJUGATES PRODUCED BY HUMAN-COLON CARCINOMA CELL-LINES WITH DIFFERENT METASTATIC POTENTIALS.  Proceedings of the American Association for Cancer Research. 63-63. 1986
  • ENHANCED TUMORIGENICITY OF TRANSFORMED NIH/3T3 CELLS WHICH PRODUCE RETROVIRAL P15E.  Proceedings of the American Association for Cancer Research. 44-44. 1985
  • GLYCOPROTEIN ANALYSIS OF HUMAN RECTUM AND SIGMOID COLON CARCINOMAS AT VARIOUS STAGES OF METASTASES USING LECTINS.  Proceedings of the American Association for Cancer Research. 49-49. 1985
  • PERCENT DISTRIBUTION OF ESTRADIOL (E2) IN SERA OF WOMEN WITH BREAST-CANCER (BCA) AND DISEASE-FREE WOMEN WITH (FHCA) AND WITHOUT (NOFHCA) A FAMILY HISTORY OF BREAST-CANCER.  Proceedings of the American Association for Cancer Research. 197-197. 1985
  • NUTRITIONAL-STATUS AND ERYTHROCYTE (RBC) POLYAMINES (PA) LEVELS IN FIBRO-SARCOMA BEARING RATS.  Proceedings of the American Association for Cancer Research. 51-51. 1984
  • THE ESTABLISHMENT OF A LYMPHOHEMOPOIETIC STEM-CELL LINE, A NEW MODEL FOR THE STUDY OF CELLULAR-DIFFERENTIATION.  Proceedings of the American Association for Cancer Research. 44-44. 1984
  • NUTRITIONAL-STATUS AND ANTI-TUMOR ACTIVITY OF CYCLOPHOSPHAMIDE (CP) AGAINST L1210 LEUKEMIA.  Proceedings of the American Association for Cancer Research. 307-307. 1983
  • ANDROGEN STIMULATION OF BREAST CYST FLUID ANTIGEN LEVELS IN PLASMA OF PATIENTS WITH METASTATIC BREAST-CARCINOMA.  Proceedings of the American Association for Cancer Research. 153-153. 1982
  • EFFECT OF CHEMOTHERAPY ON CALCITONIN (CT) LEVELS IN PATIENTS WITH METASTATIC MEDULLARY-THYROID CARCINOMA (MTC).  Proceedings of the American Association for Cancer Research. 155-155. 1980
  • LDH AS A PREDICTOR OF CHEMOTHERAPY RESPONSE AND SURVIVAL IN HORMONE REFRACTORY METASTATIC PROSTATE-CANCER (HRPC).  Proceedings of the American Association for Cancer Research. 414-414. 1979
  • IMMUNOLOGICAL MECHANISMS INVOLVED IN ESTABLISHMENT AND MAINTENANCE OF TUMOR DORMANT STATE.  Proceedings of the American Association for Cancer Research. 95-95. 1978
  • MAJOR PROGNOSTIC FEATURES IN METASTATIC CARCINOMA OF PROSTATE.  Proceedings of the American Association for Cancer Research. 58-58. 1978